TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Nadja M. Meindl‐Beinker, Bedair Dewidar et al.|Gut|2020Cited by 43
Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncologyBryony J. Telford, Michel Janicot|Oncotarget|2021Cited by 36